Stay updated on Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial
Sign up to get notified when there's something new on the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page.

Latest updates to the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page
- Check3 days agoChange DetectedAdded related topics: Type 1 diabetes and MedlinePlus Genetics to the page.SummaryDifference0.1%

- Check10 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. This is a minor metadata update and does not affect study details or page content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe Locations section now includes additional site locations across California, Colorado, Florida, Georgia, Illinois, Indiana, Massachusetts, New York, Pennsylvania, Tennessee, Texas, Washington, Victoria (Australia), and Ontario (Canada). The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check46 days agoChange DetectedRemoved the topic 'Type 1 diabetes' and the related topic 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded related topics for Type 1 diabetes and MedlinePlus Genetics.SummaryDifference0.2%

- Check60 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all pertain to the study, and added Revision: v3.3.2; the older PubMed wording with Revision: v3.2.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page.